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httpcense.Abstract Background: Chronic obstructive pulmonary disease (COPD) is currently the 4th lead-
ing cause of death all over the world. Smoking is by far the most important documented (and pre-
ventable) cause for COPD. However, COPD can still be recorded among a good percentage of non
smoker patients, due to other different causes.
Methods: This study was performed in the Chest Department, Menouﬁya University, in the per-
iod from April 2009 to August 2011, on randomly selected 300 COPD patients, 230 patients
(76.66%) were men and 70 patients (23.34%) were women. The mean age of the patients was
60.7 ± 5.35 years (range 42–83 years), and all patients were diagnosed as having COPD (FEV1/
FVC < 70%), with the use of spirometry (prebronchodilator and postbronchodilator inhalation),
according to the GOLD criteria. For each patient, the personal history (including his or her educa-
tion level), smoking history, health status, and exposure to risk factors for COPD, were assessed
according to a prewritten questionnaire.
Results: Out of the 300 COPD patients included in this study, 120 (40%) were never smokers
and 180 (60%) were ever smokers. Women made up 41.7% of the never smokers (50 of 120) and
11% of the ever smokers (20 of 180). Never smokers were signiﬁcantly older than smokers
[65.08 ± 5.03 years vs 56.33 ± 5.67 years (P< 0.001)] and were more likely to be women
[41.7% vs 11% (P< 0.001)]. Never smokers made up to 40% (120/300) of all COPD cases: 78%
(70/90) of all GOLD stage II cases, 45.5% (50/110) of all GOLD stage III cases. Among never
smokers, 58.3% (70/120) fulﬁlled the criteria for GOLD stage II and 41.7% (50/120) fulﬁlled the
criteria for GOLD stage III and no patients fulﬁlled the criteria of either GOLD stage I or GOLD
stage IV. Never smokers were shown to have more occupational exposure to organic and inorganic
dust and irritant gases at work place [41.7% (50/120) vs 27.7% (50/180), P< 0.05], more biomass
exposure [41.7% (50/120) vs 0% (0/180), P< 0.001], less education [41.7% (50/120) vs 72.2% (130/
180), P< 0.001], more exposure to passive smoking [75% (90/120) vs 22.2% (40/180), P< 0.001].
When compared with never smoker patients with moderate COPD (GOLD stage II), never smokersest Department, Menouﬁya
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60 R.M. Bakr, I.I. Elmahallawywith severe COPD (GOLD stage III) were older in age (70.6 ± 2.44 years vs 61.14 ± 1.25 years,
P< 0.001), have a higher female percentage (60% vs 28.6%, P< 0.001), lower BMI (21.2 ±
0.76 vs 26.14 ± 2.43, P< 0.001), more occupational exposure (27.5 ± 2.56 years vs 13.33 ±
2.39 years, P< 0.001), more biomass exposure (35 ± 4.15 years vs 20 ± 10 years, P< 0.001), less
education (0% vs 71.4 educated, P< 0.001), more exposure to passive smoking (29 ± 2.02 years vs
13.75 ± 4.19 years, P< 0.001).
Conclusions: This study revealed that never smokers constitute a signiﬁcant proportion of the
Egyptian COPD patients. When dealing with COPD management, clinicians must be oriented with
the different risk factors, other than tobacco smoke, that play a key role in the development and
pathogenesis of COPD, because despite smoking is the most important risk factor, its absence
doesn’t exclude COPD diagnosis.
ª 2012 The Egyptian Society of Chest Diseases and Tuberculosis. Production and hosting by Elsevier B.V.
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Chronic obstructive pulmonary disease (COPD) is an impor-
tant and increasing cause of morbidity and mortality world-
wide. It is the fourth leading cause of death and is projected
to rank third among all causes of death by 2020 [1].
Smoking is by far the major cause of COPD worldwide, a
fact that has been well known for at least 2 decades. COPD
is considered rare in persons with no smoking history except
in the context of another exposure, such as occupational dust,
environmental air pollution, or biomass fuel. Accordingly, the
disease has not been well characterized in persons who have
never smoked [2–4].
However, in the past decade and especially the past 5 years,
results from a growing number of published studies have sug-
gested that risk factors other than smoking are strongly associ-
ated with COPD. These factors include exposure to indoor and
outdoor air pollutants, workplace exposure to dust and fumes,
history of repeated lower respiratory-tract infections during
childhood, history of pulmonary tuberculosis, chronic bron-
chial asthma, intrauterine growth retardation, poor nourish-
ment, and poor socioeconomic status [5]. It is now recognized
that never smokers may account for between one-fourth and
one-third of all COPD cases [6].
Patients and methods
The study was conducted on randomly chosen 300 COPD pa-
tients aged from 42 to 83 years (60.7 ± 5.35) and (230 men and
70 women) during their admission in the Chest Department,
Menouﬁya University Hospitals or during their follow up vis-
its to the outpatient clinic of the same, from April 2009 to Au-
gust 2011. A written consent was obtained from each patient
participating in this study.
All participants included in the study performed prebron-
chodilator and postbronchodilator spirometry and recorded
a questionnaire data on personal history, smoking history,
health status, and exposure to risk factors for COPD.
Spirometry
Spirometry was performed according to American Thoracic
Society (ATS) criteria [7]. Separate measurements were made
before and at least 15 min after two puffs of Salbutamol
(200 mg) administered with a metered dose inhaler with volu-
matic spacer. Irreversible airway obstruction was deﬁned asa postbronchodilator FEV1/FVC < 0.7 according to the
GOLD (Global Initiative for Obstructive Lung Disease) guide-
lines and the FEV1 was used to further stage the disease:
FEV1 < 80% predicted served as the threshold for GOLD
stage II COPD, FEV1 < 50% predicted served as the thresh-
old for GOLD stage III COPD and FEV1 < 30% predicted
served as the threshold for GOLD stage IV COPD [8].
Questionnaire data
Questionnaire data were obtained from each patient and in-
cluded information on smoking history and risk factors for
COPD, education, comorbidities, respiratory diagnoses and
childhood diseases.
An ever smoker (current or former) was deﬁned as a person
who had smoked >20 packs of cigarettes in a lifetime or >1
cigarette/d for a year. Exposure to passive cigarette smoke
was deﬁned as an answer to whether anyone (other than the
participant) had smoked a cigarette, pipe, cigar or shisha in
the participant’s home or workplace. To assess occupational
exposure, participants were asked whether they had worked
>3 months in occupations known or suspected to be associ-
ated with the risk of COPD and, if so, the number of years
spent in each occupation. Occupational exposures were
grouped into three categories: organic dust, inorganic dust
and irritant gases, fumes, or vapors. Biomass exposure was
recorded if the participant had experienced at least 6 months
use of indoor ﬁre for cooking or heating. Participants also
reported the number of years of biomass exposure.
Additional measures evaluated included body mass index
[BMI (kg/m2)]; total number of years of education; self-reported
hospitalizations for respiratory problems prior to the age of
10 years; and self-reported physician-diagnosed bronchial
asthma, COPD, chronic bronchitis, emphysema or TB.
Results
A total of 300 COPD patients had acceptable postbronchodi-
lator spirometry data and completed the questionnaires. Of
this group, 120 (40%) were never smokers and 180 (60%) were
smokers. Women made up 41.7% of never smokers (50 of 120)
and 11% of ever smokers (20 of 180).
Characteristics of the study population in smokers and
never smokers are summarized in Table 1. Never smokers were
signiﬁcantly older than smokers [65.08 ± 5.03 years vs
56.33 ± 5.67 years (P< 0.001)] and were more likely to be
Table 1 Population characteristics in smokers and never smokers.
Never Smokers (n= 120) Smokers (n= 180) X2 P value
No (%) No (%)
Age; years (mean ± SD) 65.08 ± 5.03 56.33 ± 5.67 13.69* <0.001
Sex
Males, No (%) 70 58.3 160 89 37.58 <0.001
Females, No (%) 50 41.7 20 11
BMI; kg/m2 (mean ± SD) 24.08 ± 3.11 25.28 ± 4.45 2.51* <0.05
FEV1/FVC (mean ± SD) 57.83 ± 4.41 47 ± 8.38 13* <0.001
FEV1% (mean ± SD) 50.33 ± 7.38 36.17 ± 8.04 15.45* <0.001
FEV1 < 80% P50% predicted (GOLD stage II) 70 58.3 20 11.1 76.46 <0.001
FEV1 < 50% >30% predicted (GOLD stage III) 50 41.7 60 33.3 2.15 >0.05
FEV1 6 30% predicted (GOLD stage IV) 0 0 100 55.6 100 <0.001
Occupational exposure
Yes 50 41.7 50 27.8 6.25 <0.05
No 70 58.3 130 72.2
Biomass exposure
Yes 50 41.7 0 0 90 <0.001
No 70 58.3 180 100
Education
Yes 50 41.7 130 72.2 28.01 <0.001
No 70 58.3 50 27.8
Passive smoking
Yes 90 75 40 22.2 81.67 <0.001
No 30 25 140 77.8
Physician diagnosed chest disease
Yes 70 58.3 150 83.3
No 50 41.7 30 16.7 23.01 <0.001
Childhood hospitalization
Yes 40 33.3 20 11 22.22 <0.001
No 80 66.7 160 89
* t Test.
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to 40% (120/300) of all COPD cases: 78% (70/90) of all
GOLD stage II cases, 45.5% (50/110) of all GOLD stage III
cases. Among overall never smokers, 58.3% (70/120) fulﬁlled
the criteria for GOLD stage II and 41.7% (50/120) fulﬁlled
the criteria for GOLD stage III. No patients among this group
fulﬁlled the criteria of either GOLD stage I or GOLD stage IV.
Never smokers had higher FEV1/FVC ratio [57.83 ± 4.41 vs
47 ± 8.38 (P< 0.001)], higher FEV1% [50.33 ± 7.38
vs 36.17 ± 8.04 (P< 0.001)] and lower BMI [24.08 ± 3.11
vs 25.28 ± 4.45 (P< 0.05)] than ever smokers.
Never smokers reported more occupational exposure to or-
ganic and inorganic dust and irritant gases at work place
[41.7% (50/120) vs 27.7% (50/180), P< 0.05], more biomass
exposure [41.7% (50/120) vs 0% (0/180),P< 0.001], less educa-
tion [41.7% (50/120) vs 72.2% (130/180), P< 0.001], more
exposure to passive smoking [75% (90/120) vs 22.2% (40/180),
P< 0.001], less physician diagnosed chest disease [58.3% (70/
120) vs 83.3% (150/180), P< 0.001] and more hospitalization
due to respiratory problems during childhood [33.3% (40/120)
vs 11% (20/180), P< 0.001] than smokers (Table 1).
Among never smokers, Table 2 compares between patients
with moderate COPD (GOLD stage II) and those with severe
COPD (GOLD stage III) regarding the demographic data and
exposure to different risk factors. Table 2 shows that neversmokers with severe COPD (GOLD stage III) were older in
age (70.6 ± 2.44 years vs 61.14 ± 1.25 years, P< 0.001), have
a higher female percentage (60% vs 28.6%, P< 0.001), lower
BMI (21.2 ± 0.76 vs 26.14 ± 2.43, P< 0.001), more occupa-
tional exposure (27.5 ± 2.56 years vs 13.33 ± 2.39 years,
P< 0.001), more biomass exposure (35 ± 4.15 years vs
20 ± 10 years, P< 0.001), less education (0% vs 71.4 edu-
cated, P< 0.001), more exposure to passive smoking
(29 ± 2.02 years vs 13.75 ± 4.19 years, P< 0.001), higher
percentage of physician diagnosed chest diseases (80% vs
42.85%, P< 0.001) and more childhood hospitalizations
(80% vs 0%, P< 0.001) than never smokers with moderate
COPD (GOLD stage II).
Table 3 shows an association between increasing age and
increasing odds of COPD severity (OR = 2.1 and P< 0.05
for ages from 50 to 59 years and OR= 2.7 and P< 0.05 for
ages from 60 to 75 years). There was also an association be-
tween female sex and COPD severity in never smokers
(OR = 1.9 and P< 0.05). Occupational exposure and bio-
mass exposure were signiﬁcantly associated with the occur-
rence and severity of COPD among never smokers
(OR = 1.09 and P< 0.05 and OR= 1.26 and P< 0.05
respectively). The table shows also an association between edu-
cation less than 9 years and increasing odds of COPD severity
(OR = 0.96 and P< 0.05).
Table 2 Population characteristics among never smokers according to the GOLD stage.
Characteristic GOLD II (n= 70) GOLD III (n= 50) t Test P value
Age; years (mean ± SD) 61.14 ± 1.25 70.6 ± 2.44 27.72 <0.001
Sex
Males, No (%) 50 71.4 20 40 11.85 <0.001
Females, No (%) 20 28.6 30 60
BMI; kg/m2 (mean ± SD) 26.14 ± 2.43 21.2 ± 0.76 13.88 <0.001
Occupational exposure; years (mean ± SD) 13.33 ± 2.39 (n= 30) 27.5 ± 2.56 (n= 20) 19.91 <0.001
Biomass exposure; years (mean ± SD) 20 ± 10 (n= 20) 35 ± 4.15 (n= 30) 16.1 <0.001
Education
ve 20(28.6) 50(100) 61.22* <0.001
+ve 50(71.4) 0(0)
Passive smoking; years (mean ± SD) 13.75 ± 4.19 (n= 40) 29 ± 2.02 (n= 50) 22.64 <0.001
Physician diagnosed chest disease; No (%) 30 42.85 40 80 16.56 <0.001
Childhood hospitalization; No (%) 0 0 40 80 84 <0.001
* t Test.
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of COPD in never smokers and any of the following predic-
tors: BMI (OR= 0.36 and P> 0.05 for BMI between 25Table 3 Multivariate logistic analysis of independent predic-
tors of COPD severity among never smokers.
Characteristic OR P value 95% CI
Age in years
40–49 Reference
50–59 2.1 <0.05 1.02–1.93
60–75 2.7 <0.05 1.13–2.3
Sex
Males Reference
Females 1.9 <0.05 1.4–1.26
BMI, kg/m2
20 6 BMI h 25 Reference
25 6 BMI h 30 0.36 >0.05 0.38–1.61
BMIP 30 0.32 >0.05 0.29–1.5
Occupational exposure




Exposed 1.26 <0.05 0.38–0.82
Education (years)




Exposed 0.22 >0.05 0.82–1.05
Physician diagnosed chest disease
No Reference
Yes 0.43 >0.05 0.73–1.62
Childhood hospitalization
No Reference
Yes 1.01 >0.05 0.9–1.93and 30 kg/m2 and OR= 0.32 and P> 0.05 for BMIP
30 kg/m2), exposure to passive smoking (OR= 0.22 and
P> 0.05), physician diagnosed chest disease (OR = 0.43
and P> 0.05) and hospitalization due to respiratory problems
prior to the age of 10 years (OR = 1.01 and P> 0.05).Discussion
This study shows that 40% of the included COPD patients
were never smokers (120/300). Never smokers constituted
78% (70/90) of all GOLD stage II cases, 45.5% (50/110) of
all GOLD stage III cases. These ﬁndings coincide with those
reported by Zhou et al. [9] who studied the prevalence of
COPD in Chinese nonsmokers; they found that 38.6% of
COPD patients were never smokers. Also, Lamprecht et al.
[10] found that 28% of irreversible airways obstruction––about
33% of mild airway obstruction (GOLD stage I) and about
23% of moderate to very severe airway obstruction (GOLD
stage II+) occurs in never smokers aged 40–98 years. In agree-
ment with our results, an analysis of (prebronchodilator)
NHANES III (National Health and Nutrition Examination
Survey) data in US adults (aged 18–80 years), Behrendt CE
showed that about one fourth of COPD cases occurred in sub-
jects with no smoking history [11]. Bridevaux et al. [12] studied
the prevalence of airﬂow obstruction in smokers and never-
smokers in Switzerland and reported that never smokers con-
stituted 29.3% of subjects with airﬂow obstruction.
Higher percentage of prevalence was found by Brashier et
al. [13] who stated that the proportion of COPD patients
who never smoked among 12055 participants above 45 years
in India was 68.6%. Also, Ehrlich et al. [14] reported that
never smokers made up 47.6% of patients with airway obstruc-
tion among 13826 adults in South Africa aged more than
18 years. In both studies, a respiratory symptoms question-
naire was used to deﬁne airway obstruction.
On the other hand, lower percentages of prevalence were re-
ported by other authors. Celli BR and colleagues [15] sug-
gested some degree of airway obstruction in 91.2 per 1000 of
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leagues [16] reported rates of ‘‘low lung function’’ in never
smokers ranging from 26 to 48 per 1000. Meyer and colleagues
reported that 16.7% of adults who died with COPD had never
smoked [17].
These results suggest that nonsmokers represent a signiﬁcant
proportion of obstructive lung disease in different sites of the
world. This variation among different rates of prevalence may
be attributed to several factors including the exposure to differ-
ent local risk factors among different countries, the variations
among the populations studied regarding the demographic data
like age, gender and ethnicity, and the differences in the deﬁni-
tions of low lung function or airway obstruction and the meth-
ods used to demonstrate it in different studies.
In the present study, never smokers were signiﬁcantly older
than smokers (65.08 ± 5.03 years vs 56.33 ± 5.67 years,
P< 0.001), never smokers with severe COPD (GOLD stage
III) were older in age (70.6 ± 2.44 years vs 61.14 ± 1.25 years,
P< 0.001) than never smokers with moderate COPD (GOLD
stage II) and we found an association between increasing age
and COPD severity (OR = 2.1 and P< 0.05 for ages from
50 to 59 years and OR= 2.7and P< 0.05 for ages from 60
to 75 years).
These results are consistent with those reported by
Lamprecht et al. [10] that showed a strong association between
increasing age and increasing odds of GOLD stage II +
COPD. Also, Celli et al. [15] concluded that the prevalence
of airﬂow obstruction appeared to increase with age.
Our results showed that never smokers were more likely to
be women (41.7% vs 11%, P< 0.001) than ever smokers.
Table 2 shows that never smokers with severe COPD (GOLD
stage III) have a higher female percentage (60% vs 28.6%,
P< 0.001) than never smokers with moderate COPD (GOLD
stage II). There was an association between female sex and
COPD severity in never smokers (OR = 1.9 and P< 0.05).
Corresponding results were reported by many authors as
Miravitlles et al. [18], Xu et al. [19], Silverman et al. [20],
Dransﬁeld et al. [21], Zhou et al [9], Lamprecht et al. [10]
and Bridevaux et al. [12]. They found that the majority of non-
smoking COPD patients were females with a strong associa-
tion between female sex and COPD severity in never smokers.
Occupational airborne dust is the best documented risk fac-
tor for development of COPD after smoking [15], with several
studies showing independent associations with decreased lung
function in nonsmokers among speciﬁc occupational groups
[22–24], and in the general population [25,26]. In 2003, results
of a systematic epidemiological review into occupational fac-
tors associated with COPD by the American Thoracic Society
(ATS), showed that about 10% to 20% of both symptoms and
functional impairment consistent with COPD might be attrib-
utable to workplace exposure [27] and a subsequent follow-up
provided similar estimates [28]. Our data conﬁrmed this ﬁnd-
ing by showing that never smokers reported more occupational
exposure to organic and inorganic dust and irritant gases at
work place (41.7% vs 27.7%, P< 0.05) than ever smokers.
Also, never smokers with severe COPD (GOLD stage III)
had more years of occupational exposure (27.5 ± 2.56 years
vs 13.33 ± 2.39 years, P< 0.001) than never smokers with
moderate COPD (GOLD stage II). Lastly, occupational expo-
sure was an independent predictor of COPD and was signiﬁ-
cantly associated with the severity of COPD among never
smokers (OR = 1.09 and P< 0.05).Coinciding with our results, Hnizdo and colleagues [29]
conﬁrmed the adverse effects of occupational exposures in an
analysis of NHANES III data and attributed 31.1% of COPD
in never smokers to these exposures. Also, Behrendt CE [11]
identiﬁed several occupations that were associated with high
prevalence of COPD: plastic, textile, rubber, and leather man-
ufacture; transportation; manufacture of food products; auto-
motive repair; and some personal services (e.g., beauty care).
The proportion of patients with COPD attributable to occupa-
tion was about 19% overall and 31% in never-smokers.
Weinmann et al. [30] reported increased prevalence of COPD
in occupations associated with chronic exposure to diesel
exhaust (e.g., garages and mines) and other irritant gases and
vapors. Trupin et al. [31] found a population-attributable frac-
tion for COPD associated with occupational exposure varying
between 9% and 31%. Lamprecht et al. [10] postulated that
never smokers with moderate to severe COPD reported expo-
sure to organic dusts in the workplace more often than did
never smokers with unobstructed airways (30.4% vs 23%).
Worldwide, about 50% of all households and 90% of rural
households use biomass fuel (wood, charcoal, other vegetable
matter, and animal dung) and coal as their main source of
domestic energy. About 3 billion people worldwide are ex-
posed to smoke from biomass fuel compared with 1.01 billion
people who smoke tobacco, suggesting that exposure to bio-
mass smoke is one of the most important global risk factors
for COPD. About 50% of deaths from COPD in developing
countries are attributable to biomass smoke [32,33].
Our results showed that never smokers reported more bio-
mass exposure (41.7% vs 0%, P< 0.001) than smokers and
never smokers with severe COPD (GOLD stage III) reported
more years of biomass exposure (35 ± 4.15 years vs
20 ± 10 years, P< 0.001) than never smokers with moderate
COPD (GOLD stage II). Biomass exposure was signiﬁcantly
associated with the occurrence and severity of COPD among
never smokers (OR = 1.26 and P< 0.05).
These ﬁndings were consistent with those reported by Smith
KR [34], Chan-Yeung et al. [35], Ezzati [36], Oroczo-Levi et al.
[37], Ekici et al. [38], Ramı´rez-Venegas et al. [39] and Lampr-
echt et al. [10]; all of them found an association between the
development of COPD in never smokers and biomass exposure
and reported it as an independent predictor of COPD among
never smokers.
Regarding the level of education, never smokers reported
less education (41.7% vs 72.2%, P< 0.001) than smokers.
Never smokers with severe COPD (GOLD stage III) have less
education (0% vs 71.4 educated, P< 0.001) than never smok-
ers with moderate COPD (GOLD stage II). Also, there is an
association between education less than 9 years and increasing
odds of COPD severity (OR = 0.96 and P< 0.05).
These results agree with those found by Nizankowska-
Mogilnicka et al. [40] who postulated that low level of educa-
tion has been shown to be associated with a higher prevalence
of COPD. Also, in agreement with our data, Lamprecht et al.
[10] reported that more years of education was associated with
lower odds of spirometrically determined COPD among
female never smokers.
In the present study, although no signiﬁcant association
was found between the severity of COPD in never smokers
and exposure to passive smoking (OR= 0.22 and P> 0.05),
never smokers reported more exposure to passive smoking
(75% vs 22.2%, P< 0.001) than smokers and never smokers
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exposure to passive smoking (29 ± 2.02 years vs 13.75 ±
4.19 years, P< 0.001) than those with moderate COPD
(GOLD stage II).
By reviewing the results of other studies, Yin et al. [41],
Eisner et al. [42], Simoni et al. [43], Iribarren et al. [44] and
Larsson et al. [45] reported that exposure to environmental to-
bacco smoke (ETS) is associated with COPD. Lamprecht [10]
did not observe an increased risk of GOLD stage II + COPD
associated with exposure to passive smoking and Celli BR [15]
found a nonsigniﬁcant decrease in the odds of obstruction
among never smokers who reported exposure to environmen-
tal tobacco smoke.
As regards the BMI, it has been recognized as a prognostic
factor and a predictor of death in COPD [46] and has shown
an association with bronchial hyperresponsiveness [47]. Our
data showed that never smokers had lower BMI (24.08 ±
3.11 vs 25.28 ± 4.45 P< 0.05) than ever smokers, and never
smokers with severe COPD (GOLD stage III) had lower
BMI (21.2 ± 0.76 vs 26.14 ± 2.43, P< 0.001), than never
smokers with moderate COPD (GOLD stage II). No signiﬁ-
cant association was found between the severity of COPD in
never smokers and BMI (OR= 0.36 and P> 0.05 for BMI
between 25 and 30 kg/m2 and OR= 0.32 and P> 0.05 for
BMIP 30 kg/m2). Celli et al. [15] found an increased likeli-
hood of obstruction in those with lower BMI and Lamprecht
et al. [10] reported increased odds of GOLD stage in the never
smoker population with low BMI (<20 kg/m2).
Never smokers reported less physician diagnosed chest dis-
ease (58.3% vs 83.3%, P< 0.001) and more hospitalizations
due to respiratory problems during childhood (33.3% vs
11%, P< 0.001) than smokers. Also, never smokers with
GOLD stage III COPD reported a higher percentage of physi-
cian diagnosed chest diseases (80% vs 42.85%, P< 0.001) and
more childhood hospitalizations (80% vs 0%, P< 0.001) than
never smokers with moderate COPD (GOLD stage II).
No signiﬁcant association was found between the severity
of COPD in never smokers and either physician diagnosed
chest disease (OR = 0.43 and P> 0.05) or hospitalization
due to respiratory problems prior to the age of 10 years
(OR = 1.01 and P> 0.05). Lamprecht et al. [10] reported that
81.2% of never smokers with moderate to severe airway
obstruction were previously undiagnosed. Also, they found
that severe childhood respiratory infections or other breathing
problems (leading to hospitalization) and COPD were associ-
ated in never smokers. Berglund et al. [48] reported an associ-
ation between COPD in never smokers and history of
childhood disease. Silva et al. [49], Ulrik CS and Lange P
[50], Abhyankar and Salvi [51] and Celli et al. [15] found an
association between COPD and physician diagnosed chronic
chest diseases especially bronchial asthma. Ehrlich et al. [14]
suggested an association between COPD and history of pul-
monary tuberculosis.
Conclusion
This study revealed that never smokers constitute a substantial
proportion of COPD patients. Multiple risk factors, other than
tobacco smoke, play a key role in the development and path-
ogenesis of COPD as increasing age, female gender, exposure
to occupational irritants, exposure to biomass fuels, as occur-ring in Egyptian village inhabitants, low educational level,
exposure to environmental tobacco smoke, low BMI, history
of childhood chest diseases and history of physician diagnosed
chronic chest diseases.
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